Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.18 Billion |
|---|---|
| Enterprise Value | $-41,399,460,256.00 |
| Annual dividend | $0.25 |
| Dividend yield | 1.97% |
| Earnings per Share | $115.04 |
| Beta | 0.24 |
| Outstanding Shares | 321,640,257 |
| P/E Ratio | 16.91 |
|---|---|
| PEG | 1819.88 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | 12.89 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.12 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addr...